VANAC-MR
VANAC-MR is a pharmaceutical tablet formulation containing Diclofenac Potassium, Paracetamol and Chlorzoxazone. The combination brings together three established pharmaceutical ingredients in a single oral dosage form. Diclofenac Potassium belongs to the non-steroidal anti-inflammatory drug (NSAID) class, Paracetamol is an analgesic and antipyretic agent, and Chlorzoxazone is a centrally acting muscle relaxant.
Each tablet contains Diclofenac Potassium 50 mg, Paracetamol 325 mg and Chlorzoxazone 250 mg, subject to confirmation against the approved product specification. The formulation is presented as VANAC-MR Tablets for inclusion in pharmaceutical product catalogues serving hospitals, pharmacies, medical practitioners and healthcare procurement teams.
VANAC-MR is supplied in a blister-pack presentation, with a pack size of 10 strips of 10 tablets each. Its product information identifies the active ingredients, dosage form and pack configuration to support accurate product listing, inventory identification and pharmaceutical procurement processes.
Everything You, Need to Know
The listed pack size is 10 × 10 tablets, equivalent to 100 tablets per pack.
VANAC-MR is presented as an oral tablet formulation.
The corresponding formulation record lists Diclofenac Potassium 50 mg, Paracetamol 325 mg and Chlorzoxazone 250 mg per tablet. Confirm these strengths against the approved VANAC-MR specification before publication.